Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19
Teicoplanin is a glycopeptide antibiotic effective against several bacterial infections, has exhibited promising therapeutic efficiency against COVID-19 in vitro<i>,</i> and the rationale for its use in COVID-19 is yet to be recognized. Hence, in this study a number of molecular modeling...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/7/856 |